-
2-(2-imino-2,3,4,5,6,7-hexahydro-1,3-benzothiazol-3-yl)-1-(4-methylphenyl)ethan-1-one hydrobromide
-
ChemBase ID:
133304
-
Molecular Formular:
C16H19BrN2OS
-
Molecular Mass:
367.30386
-
Monoisotopic Mass:
366.04014624
-
SMILES and InChIs
SMILES:
Cc1ccc(cc1)C(=O)Cn1c2c(sc1=N)CCCC2.Br
Canonical SMILES:
Cc1ccc(cc1)C(=O)Cn1c(=N)sc2c1CCCC2.Br
InChI:
InChI=1S/C16H18N2OS.BrH/c1-11-6-8-12(9-7-11)14(19)10-18-13-4-2-3-5-15(13)20-16(18)17;/h6-9,17H,2-5,10H2,1H3;1H
InChIKey:
HAGVCKULCLQGRF-UHFFFAOYSA-N
-
Cite this record
CBID:133304 http://www.chembase.cn/molecule-133304.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
2-(2-imino-2,3,4,5,6,7-hexahydro-1,3-benzothiazol-3-yl)-1-(4-methylphenyl)ethan-1-one hydrobromide
|
|
|
IUPAC Traditional name
|
2-(2-imino-4,5,6,7-tetrahydro-1,3-benzothiazol-3-yl)-1-(4-methylphenyl)ethanone hydrobromide
|
|
|
Synonyms
|
2-(2-Imino-4,5,6,7-tetrahydrobenzothiazol-3-yl)-1-p-tolylethanone hydrobromide
|
PFT-α
|
Pifithrin-α
|
Pifithrin-α
|
|
|
CAS Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
15.250456
|
H Acceptors
|
3
|
H Donor
|
1
|
LogD (pH = 5.5)
|
2.7600198
|
LogD (pH = 7.4)
|
3.5309336
|
Log P
|
3.55956
|
Molar Refractivity
|
96.4317 cm3
|
Polarizability
|
31.972496 Å3
|
Polar Surface Area
|
44.16 Å2
|
Rotatable Bonds
|
3
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
P4359
|
Biochem/physiol Actions Pifithrin-α is a reversible inhibitor of p53-mediated apoptosis and p53-dependent gene transcription such as cyclin G, p21/waf1, and mdm2 expression. Pifithrin-α enhances cell survival after genotoxic stress such as UV irradiation and treatment with cytotoxic compounds including doxorubicin, etopoxide, paclitaxel, and cytosine-β-D-arabinofuranoside. Pifithrin-α protects mice from lethal whole body γ-irradiation without an increase in cancer incidence. The protective effect is not seen in p53-null mice or cells expressing a dominant negative mutant of the p53 gene. Protection is conferred by the transient expression of p53 in p53-deficient cell lines. |
PATENTS
PATENTS
PubChem Patent
Google Patent